CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Cadre Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$27.07+0.69 (+2.62%)
Close on Oct 19, 2026
- Market cap
- $1.17B
- P/E (TTM)
- 33.4
- Dividend yield
- 1.40%
Share price
−$13.62 (−33.47%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
Cadre Holdings, Inc. grew revenue 19.7% to $685.65M over the twelve months to Jun 30, 2026. Operating income rose 9.5% to $69.07M, moving the operating margin from 11.0% to 10.1%. Free cash flow was $78.12M, up 133.6% from a year earlier.
Revenue
$685.65M
+19.7% vs. a year earlier
Operating income
$69.07M
+9.5% vs. a year earlier
Free cash flow
$78.12M
+133.6% vs. a year earlier
EPS, diluted
$0.81
-13.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.17B
- P/E ratio
- 33.4
- Price to sales
- 1.71
- Price to book
- 3.39
- Dividend yield
- 1.40%
- Free cash flow yield
- 6.65%
Fundamentals
- Revenue
- $685.65M
- Net income
- $36.06M
- EPS, diluted
- $0.81
- Free cash flow
- $78.12M
- Book value per share
- $7.99
- Diluted shares
- 43M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$685.65M+19.7% YoY
Gross profit
$286.55M+20.6% YoY
Operating income
$69.07M+9.5% YoY
Net income
$36.06M-5.3% YoY
EPS, diluted
$0.81-13.8% YoY
Free cash flow
$78.12M+133.6% YoY
Reported periodTrailing twelve months